BRAINSIM Trademark

Trademark Overview

On Monday, April 13, 2020, a trademark application was filed for BRAINSIM with the United States Patent and Trademark Office. The USPTO has given the BRAINSIM trademark a serial number of 88870154. The federal status of this trademark filing is REGISTERED as of Tuesday, December 21, 2021. This trademark is owned by AxoSim, Inc.. The BRAINSIM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and technological services, namely, sample analysis in the field of pharmaceuticals, cosmetics, biotechnology or chemicals
brainsim

General Information

Serial Number88870154
Word MarkBRAINSIM
Filing DateMonday, April 13, 2020
Status700 - REGISTERED
Status DateTuesday, December 21, 2021
Registration Number6592797
Registration DateTuesday, December 21, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 5, 2021

Trademark Statements

Goods and ServicesScientific and technological services, namely, sample analysis in the field of pharmaceuticals, cosmetics, biotechnology or chemicals
Pseudo MarkBRAIN SIM

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 21, 2020
Primary Code042
First Use Anywhere DateWednesday, May 13, 2020
First Use In Commerce DateWednesday, May 13, 2020

Trademark Owner History

Party NameAxoSim, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew Orleans, LA 70112
Party NameAxoSim, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Orleans, LA 70112
Party NameAxoSim, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Orleans, LA 70112

Trademark Events

Event DateEvent Description
Tuesday, December 21, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, October 5, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 5, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 15, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, August 28, 2021NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Friday, August 27, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 27, 2021USE AMENDMENT ACCEPTED
Tuesday, August 24, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 23, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 23, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sunday, March 14, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Sunday, March 14, 2021FINAL REFUSAL E-MAILED
Sunday, March 14, 2021FINAL REFUSAL WRITTEN
Tuesday, February 16, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 15, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 15, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 21, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 21, 2021NON-FINAL ACTION E-MAILED
Thursday, January 21, 2021NON-FINAL ACTION WRITTEN
Tuesday, December 22, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 21, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 21, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 22, 2020AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, December 22, 2020USE AMENDMENT FILED
Monday, December 21, 2020TEAS AMENDMENT OF USE RECEIVED
Thursday, October 22, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, July 6, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 6, 2020NON-FINAL ACTION E-MAILED
Monday, July 6, 2020NON-FINAL ACTION WRITTEN
Monday, June 29, 2020ASSIGNED TO EXAMINER
Tuesday, April 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 16, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

brainsim pharmaceuticals cosmetics biotechnology chemicals field analysis technological services namely sample